Publications by authors named "Marine Demarquet"

Article Synopsis
  • The study is trying to help families make tough choices about stopping life-support in emergency rooms when patients can't talk.
  • They will create a special program to help families, doctors, and nurses with these decisions and check how it affects the stress levels of the families.
  • The research will take place in nine emergency departments in France and will measure how families feel after 7, 30, and 90 days, making sure everything follows ethical rules.
View Article and Find Full Text PDF

Introduction: Anterior shoulder dislocation is a common reason for consultation at the emergency department (ED). Hypnosis could be a safe and effective alternative therapy for pain relief during shoulder dislocation reduction but nowadays, evidence is not sufficient. The main objective of this study is to show that reduction under hypnosis is associated with a decrease in the use of analgesic compared with usual care.

View Article and Find Full Text PDF

Background: We hypothesized that monitoring the volume of activity and overall performance indicators is not sufficient to understand the underlying differences between emergency departments. We aimed to understand the underlying common characteristics of emergency departments and map their typology in order to propose adaptive solutions, that would take into account territorial specificities and manage existing resources.

Methods: We applied a multifactorial analysis based on input data at three levels; 1) the health care available in the area surrounding the emergency departments, 2) the level of medical technicality of the hospitals and 3) the profile of emergency department visits.

View Article and Find Full Text PDF

Second-generation tyrosine kinase inhibitors (TKI 2) represent a recent important improvement in the treatment of Philadelphia positive leukemias. These agents are a suitable major option if resistance or significant imatinib intolerance occurs in chronic and accelerated phase CML. They are now introduced as first line therapy in chronic phase CML where they induce cytogenetic and molecular response rates never seen to date, which is promising for long-term survival.

View Article and Find Full Text PDF